Close Menu
GeekBlog

    Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    What's Hot

    The best power banks of 2025: Expert tested and reviewed

    October 4, 2025

    Boston appeals court blocks Trump administration curbs on birthright citizenship

    October 4, 2025

    7 Best MagSafe Phone Grips (2025), Tested and Reviewed

    October 4, 2025
    Facebook X (Twitter) Instagram Threads
    GeekBlog
    • Home
    • Mobile
    • Reviews
    • Tech News
    • Deals & Offers
    • Gadgets
      • How-To Guides
    • Laptops & PCs
      • AI & Software
    • Blog
    Facebook
    GeekBlog
    Home»Blog»FDA approves Evita Solutions' generic mifepristone amid conservative backlash
    Blog

    FDA approves Evita Solutions' generic mifepristone amid conservative backlash

    Michael ComaousBy Michael ComaousOctober 3, 20252 Mins Read
    Share Facebook Twitter Pinterest LinkedIn Tumblr Email Copy Link
    FDA approves Evita Solutions' generic mifepristone amid conservative backlash
    Share
    Facebook Twitter LinkedIn Pinterest Email Copy Link

    The Food and Drug Administration approved another generic version of the abortion pill mifepristone last month, drawing criticism from abortion opponents and some Republican lawmakers [pbs.org#1][cbsnews.com#4][axios.com#5]. The newly approved version is made by Evita Solutions, which highlighted the product on its website this week, and federal health officials emphasized that the FDA has limited discretion by law when a generic matches the original drug [axios.com#5].

    Highlights:

    • Who was approved: The FDA last month approved a generic mifepristone made by Evita Solutions, which the company promoted on its website this week [axios.com#5].
    • Approval mechanics: Generic approvals focus on whether a copycat matches the original, giving the FDA very limited discretion under federal law [axios.com#5].
    • Conservative reaction: Abortion opponents, including Susan B. Anthony Pro-Life America, criticized the move, and Sen. Josh Hawley voiced distrust in FDA leadership [axios.com#5][cbsnews.com#4][pbs.org#1].
    • HHS position: An HHS spokesman said the agency has 'very limited discretion' in deciding whether to approve a generic drug [axios.com#5].
    • Policy context: The approval follows statements from Health Secretary Robert F. Kennedy Jr. and FDA Commissioner Marty Makary that they were studying adding new safety limits to mifepristone [axios.com#5][nypost.com#3].

    I have lost confidence in the leadership at FDA. – Sen. Josh Hawley

    Perspectives:

    • HHS spokesman Andrew Nixon: Said the FDA has very limited discretion by law when deciding whether to approve a generic drug. (Axios)
    • Susan B. Anthony Pro-Life America: Called the decision 'unconscionable.'. (Axios)
    • Sen. Josh Hawley: Criticized the agency’s leadership following the approval. (Axios)
    • HHS Secretary Robert F. Kennedy Jr.: Indicated the FDA was bound by federal law to approve the drug, even as officials study safety limits. (New York Post)

    Sources:

    • FDA approves another generic abortion pill, prompting conservative backlash – pbs.org
    • ‘SHOCKING’: FDA Approves New Abortion Drug – dailysignal.com
    • FDA approves another abortion pill after RFK Jr. pledged to review safety of mifepristone – outraging conservatives – nypost.com
    • FDA approves another generic abortion pill – cbsnews.com
    • FDA okays new generic abortion drug, outraging conservatives – axios.com
    approves backlash conservative Evita FDA generic mifepristone Solutions039
    Share. Facebook Twitter Pinterest LinkedIn Tumblr Telegram Email Copy Link
    Previous ArticleArs Live: Is the AI bubble about to pop? A live chat with Ed Zitron.
    Next Article China Is Leading the World in the Clean Energy Transition. Here’s What That Looks Like
    Michael Comaous
    • Website

    Michael Comaous is a dedicated professional with a passion for technology, innovation, and creative problem-solving. Over the years, he has built experience across multiple industries, combining strategic thinking with hands-on expertise to deliver meaningful results. Michael is known for his curiosity, attention to detail, and ability to explain complex topics in a clear and approachable way. Whether he’s working on new projects, writing, or collaborating with others, he brings energy and a forward-thinking mindset to everything he does.

    Related Posts

    2 Mins Read

    Boston appeals court blocks Trump administration curbs on birthright citizenship

    2 Mins Read

    Supreme Court lets President Trump end TPS for over 300,000 Venezuelans

    2 Mins Read

    Spanish-language journalist Mario Guevara deported after over 100 days detained

    4 Mins Read

    Trump orders Israel to halt Gaza strikes as Hamas offers releases

    2 Mins Read

    Los Angeles City Hall evacuated after car hits steps; driver detained

    1 Min Read

    Trump administration offers migrant teens $2,500 to voluntarily return

    Top Posts

    8BitDo Pro 3 review: better specs, more customization, minor faults

    August 8, 202536 Views

    What founders need to know before choosing their exit at Disrupt 2025

    August 8, 202521 Views

    Grok rolls out AI video creator for X with bonus “spicy” mode

    August 7, 202516 Views
    Stay In Touch
    • Facebook

    Subscribe to Updates

    Get the latest tech news from FooBar about tech, design and biz.

    Most Popular

    8BitDo Pro 3 review: better specs, more customization, minor faults

    August 8, 202536 Views

    What founders need to know before choosing their exit at Disrupt 2025

    August 8, 202521 Views

    Grok rolls out AI video creator for X with bonus “spicy” mode

    August 7, 202516 Views
    Our Picks

    The best power banks of 2025: Expert tested and reviewed

    October 4, 2025

    Boston appeals court blocks Trump administration curbs on birthright citizenship

    October 4, 2025

    7 Best MagSafe Phone Grips (2025), Tested and Reviewed

    October 4, 2025

    Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    Facebook X (Twitter) Instagram Pinterest Threads
    • About Us
    • Contact us
    • Privacy Policy
    • Disclaimer
    • Terms and Conditions
    © 2025 geekblog. Designed by Pro.

    Type above and press Enter to search. Press Esc to cancel.